Topic
Patents
809 published works
Foley & Lardner LLP
Can Patent Filings Help Physical AI Companies Raise Capital?
September 2026 For autonomous systems and physical AI companies, patent cadence can be part of the fundraising story when it maps to defensible shipped technology. This article examines the latest…
Spicy IP
SpicyIP Weekly Review (14 September-20 September)
By SpicyIP
In this edition of the SpicyIP Weekly Review, we have comments submitted by a few of our team members on the IPO’s Draft Guidelines for Examination of Patent Applications in…
Spicy IP
Specific Comments on the IPO’s Draft Pharmaceutical Guidelines (2026)
There is no easier way to put it – the IPO’s Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026 (“2026 Draft Guidelines”) released 15 days…
Patent Law Weblog
Ex parte Chowdhury (PTAB 2026)
By Kevin E. Noonan –On August 25th, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office designated as Informative its decision in Ex parte Chowdhury,…
Gibson Dunn
Deal Trends — In Focus: Life Sciences
Deal Trends In Focus: Life Sciences Our partners share insights on the trends shaping dealmaking in the Life Sciences sector—and what to watch in the months ahead. .wp-block-media-text .wp-block-media-text__content{padding-left:32px;padding-right:0} .wp-block-media-text.has-media-on-the-right…
Biosimilars Law Bulletin
The Evolving Law of Enablement: Federal Circuit Decisions in Wyeth and Teva Form a “Yin and Yang” Framework
By Aydin H. Harston, Anh-Thu Lam
Two Federal Circuit decisions, three months apart, analyzed enablement of similarly broad method-of-treatment claims, but reached opposite outcomes. In April, the court reversed a JMOL of invalidity and reinstated a…
RF EMerge
The Evolving Law of Enablement: Federal Circuit Decisions in Wyeth and Teva Form a “Yin and Yang” Framework
By Aydin H. Harston, Anh-Thu Lam
Two Federal Circuit decisions, three months apart, analyzed enablement of similarly broad method-of-treatment claims, but reached opposite outcomes. In April, the court reversed a JMOL of invalidity and reinstated a…
3 Geeks and a Law Blog
Patlytics and the Patent AI Race: Paul Lee on USPTO Workflows, Human Judgment, and the AI Dividend
By Greg Lambert, Marlene Gebauer
Paul Lee, co-founder and CEO of Patlytics, joins Greg Lambert to explain how an AI platform built specifically for intellectual property work is changing the patent lifecycle. Patlytics supports workflows…
Spicy IP
Section 14 is Not Section 25: Delhi High Court Revives Sugammadex Patent Bid
By SpicyIP
The Delhi High Court’s order in Fresenius Kabi v. Controller may ultimately turn on a Section 14 violation, but the concerns it flags go well beyond procedure, extending to hindsight,…
Spicy IP
General Comment on the IPO’s Draft Pharmaceutical Guidelines (2026)
A few days ago, we had informed our readers that they could participate in the open call for comments and suggestions on the Draft Guidelines for Examination of Patent Applications…